Skip to main content
. 2020 Sep 11;2020:9690832. doi: 10.1155/2020/9690832

Figure 5.

Figure 5

Relationship between soluble Tyro3 levels, disease activity scores, and systemic disease parameters. Relationship between soluble Tyro3 (sTyro3), soluble Mer (sMer), and Gas6 levels in synovial fluid of RA patients (n = 11) and disease activity scores based on erythrocyte sedimentation rate (DAS28-ESR) (a, d, g). sTyro3 levels in patients with low (<3.2), medium (3.2–4.0), and high (>4.0) DAS28ESR scores (b, e, h). Differences between soluble Tyro3 (sTyro3) in the synovial fluid of RA patients double positive (>10 IU/ml) for rheumatoid factor (RF) and anticyclic citrullinated peptide antibody (ACPA) (16 samples), single positive for RF (2 samples) or ACPA (3 samples), and double negative (<10 IU/ml) (7 samples) (c, f, i). Data are presented as P value for each comparison (unpaired t-tests) or as Pearson r value (r) and P value (P) for correlation. ∗∗P < 0.01; ∗∗∗P < 0.001.